CN112813106A - Preparation method of zebra fish with LDLR gene deletion - Google Patents

Preparation method of zebra fish with LDLR gene deletion Download PDF

Info

Publication number
CN112813106A
CN112813106A CN202110043825.1A CN202110043825A CN112813106A CN 112813106 A CN112813106 A CN 112813106A CN 202110043825 A CN202110043825 A CN 202110043825A CN 112813106 A CN112813106 A CN 112813106A
Authority
CN
China
Prior art keywords
fish
ldlr
grna
ldlr gene
zebra fish
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202110043825.1A
Other languages
Chinese (zh)
Inventor
汪利平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110043825.1A priority Critical patent/CN112813106A/en
Publication of CN112813106A publication Critical patent/CN112813106A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K61/00Culture of aquatic animals
    • A01K61/10Culture of aquatic animals of fish
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276Knock-out vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/15Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/40Fish
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/035Animal model for multifactorial diseases
    • A01K2267/0375Animal model for cardiovascular diseases
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention constructs LDLR gene deletion zebra fish by using CRISPR/Cas9 technology, and the specific steps comprise: 1) determining an LDLR target site according to the LDLR gene sequence; 2) preparing gRNA; 3) transcribing Cas9mR NA in vitro; 4) cas9mRNA and gRNA are mixed and injected into zebra fish embryos at the single cell stage; 5) f is to be0Feeding the embryo to sexual maturity; 6) outcrossing with wild adult fish, screening F0(ii) a 7) Selection of F producing efficient mutations0Selfing and screening F1(ii) a 8) From F1Selecting female fish and male fish with the same mutation from the generation mutants, and hybridizing to obtain F2Generation; 9) screening of L DLR Gene knockout homozygotesNamely the zebra fish with the LDLR gene deletion of stable inheritance. The LDLR gene deletion zebra fish constructed by the invention can be stably inherited and can be used for researching vascular embolism.

Description

Preparation method of zebra fish with LDLR gene deletion
Technical Field
The invention belongs to the field of molecular biology, and particularly relates to preparation of zebra fish with LDLR gene deletion.
Background
The death rate of cardiovascular diseases is very high, and the death rate of cardiovascular diseases becomes the first important cause of death of human diseases, wherein the most important pathological factor is atherosclerosis, which is promoted by multiple factors, generally, the atherosclerosis is infiltrated by immune cells on the inner wall of a large and medium arterial blood vessel, lipid substances such as cholesterol, lipoid and the like are adhered to the blood vessel wall, tissue hyperplasia such as lipid stripes, lipid nuclei, calcareous deposits, fibers and the like is generated, and finally hematoma rupture, massive hemorrhage, thrombus and the like are formed, so that a series of fat metabolism disorders, neurovascular dysfunction, lumen stenosis, artery elasticity reduction and the like are caused.
LDLR is one of low-density lipoprotein receptors and hepatocyte surface receptors, and binds Apoe to remove lipoprotein particles in blood, and also interacts with lipoprotein B on LDL particles to remove LDL from blood, which is very important for removing cholesterol and triglyceride-rich lipoprotein particles in blood.
The zebra fish is a third-large vertebrate model except rats and mice, is fertilized in vitro, developed in vitro, transparent in embryo, visible in development process and large in one-time egg laying quantity, and is a good animal model for researching cardiovascular diseases.
Disclosure of Invention
The invention aims to construct an LDLR gene deleted zebra fish by using a CRISPR/Cas9 system.
The preparation process of the invention is as follows:
the DNA sequence of the target site of the invention is as follows: 5'-GGTAGCTGGAAGTGTGATGG-3' are provided.
The invention provides a gene targeting kit, which comprises two Oligo sequences with the sequence of 5'-TAGGTAGCTGGAAGTGTGATGG-3', 5'-AAACCCATCACACTTCCAGCTA-3', and can be used for silencing LDLR gene expression.
The invention provides a gene knockout method, which comprises the following steps: the Oligo fragment is used for recognizing a target site of a target gene, binding with Cas9 and recognizing a PAM sequence at the target site, guiding nuclease to bind to the target site of the target gene, starting shearing to form a DSB gap, then connecting a cell with a repair mechanism through a non-homologous end to repair a double chain of the target gene, causing frameshift mutation, and finally knocking out the target gene.
Further, the target point is one or more than one.
Further, the invention provides a preparation method of the zebra fish with the LDLR gene deletion, which comprises the following steps:
1. determining an LDLR target site according to the LDLR gene sequence;
2. designing an Oligo sequence according to the LDLR target site;
3. constructing a gRNA in vitro transcription vector;
4, PCR to obtain a gRNA in vitro transcription template;
5. carrying out in-vitro transcription on the template obtained in the step 4 to obtain gRNA;
6. preparing an in vitro transcription template of Cas9 mRNA;
7. transcribing Cas9mRNA in vitro;
8. adding a polyA sequence, and recovering Cas9 mRNA;
9. cas9mRNA and gRNA are mixed and injected into zebra fish embryos at the single cell stage;
10. f is to be0Feeding the embryo to sexual maturity;
11. outcrossing with wild adult fish, screening F0
12. Selection of F producing efficient mutations0Selfing and screening F1
13. Selecting female fish and male fish with the same mutation from the F1 generation mutants, and hybridizing to obtain F2 generation;
14. screening LDLR gene knockout homozygote to obtain the stably inherited LDLR gene deletion zebra fish.
The invention has the advantages that:
the zebra fish with the LDLR gene deletion constructed by the invention is the first case at home and abroad.
The LDLR gene deletion zebra fish constructed by the invention can be stably inherited and can be used for researching vascular embolism.
Drawings
FIG. 1: electrophoretic picture of clone framework pT7-gRNA-Bbs I
FIG. 2: PCR identification of bacterial liquid
FIG. 3: gRNA in vitro transcription template
FIG. 4: in vitro transcription of Cas9mRNA
FIG. 5: PCR and enzyme digestion identification mutant
FIG. 6: comparing CYP1B1 gene-deleted zebra fish with wild type sequence
Detailed Description
The present invention is further illustrated in detail by the following examples, which are provided only for illustrating the present invention and are not intended to limit the scope of the present invention.
Example 1: preparation of animal models of the invention
1. Laboratory animal
Wild type zebra fish (strain TU) were bred according to a standardized protocol with water temperature of 28.5 ℃ and light/dark cycle of 14h/10h, adult zebra fish were spawned and embryo collected and bred in E3 hatching fluid, and embryo and larval stages of development were expressed in hours of fertilization (hpf) or days of fertilization (dpf).
CRISPR/Cas9 Gene knockout target site design
Inquiring a zebra fish LDLR gene sequence on NCBI, designing an LDLR target site on http:// zifit.partners.org/ZiFiT/CSquarere 9 nucleic.aspx according to a CRISPR/Cas9 knockout principle, wherein the target site comprises 20 bases, and the selection standard of the target site is as follows: 5 '-GG- (N) 18-NGG-3'; wherein the 5 'GG dinucleotide is part of the T7 promoter, and the 3' end of the target site is NGG.
3. Construction of gRNA in vitro transcription vector
3.1 the gRNA cloning backbone pT7-gRNA-Bbs I was obtained by digesting pT7-gRNA with Bbs I and recovering the gel (see FIG. 1), the digestion system is shown in the following Table 1:
table 1 enzyme system:
Figure BDA0002896381140000031
3.2 ordering two oligos according to target site, oligo1 sequence 5'-TAGGTAGCTGGAAGTGTGATGG-3', oligo2 sequence 5'-AAACCCATCACACTTCCAGCTA-3';
3.3 using ddH2O respectively dissolving the oligos into 10 mu M solution, and annealing to obtain small sticky end fragments, wherein the annealing procedure is shown in Table 2;
TABLE 2 annealing procedure
Figure BDA0002896381140000032
3.4 the annealed fragment is connected with the recovered gRNA cloning skeleton pT7-gRNA-Bbs I, transformed, picked and cloned, the RV-M and Oligo2 are used as primers to carry out the PCR identification of bacterial liquid (annealing at 58 ℃, extending for 30sec, 30 cycles), the target band is about 130bp (shown in figure 2), the positive clone is picked and sent to sequencing, and clone glycerol with correct sequence is selected for preserving bacteria, improving grains, and RV-M sequence: 5'-AGCGGATAACAATTTCACACAGGA-3', see Table 3 for the linkage system;
TABLE 3 connection System
Figure BDA0002896381140000041
4. Preparation of gRNA
4.1 using T7-cr fwd and tracr rev primer pair, using constructed gRNA in vitro transcription vector as template, obtaining gRNA in vitro transcription template (annealing at 58 ℃, extending for 30sec, 40cycle, 40 mul system) by using high fidelity enzyme PCR, taking 1 mul PCR product for electrophoresis, directly recovering PCR product after confirming single band (125bp) (see figure 3), for subsequent experiment, T7-cr fwd sequence: 5'-GAAATTAATACGACTCACTATA-3', tracr rev sequence: 5'-AAAAAAAGCACCGACTCGGTGCCAC-3', respectively;
4.2 in vitro transcription of gRNAs
The gRNA in vitro transcription system is shown in Table 4;
TABLE 4 in vitro transcription of mRNA reaction System
Figure BDA0002896381140000042
4.3 recovery of gRNA
4.3.1 RNase-free water was used to dilute the gRNA transcript to 300. mu.l, 330. mu.l of absolute ethanol was added;
4.3.2 adding the solution into a recovery column, centrifuging for 15s at 10000 g/min;
4.3.3 adding 700 mul of miRNA Wash Solution I, and centrifuging for 5-10 s;
4.3.4 adding 500 μ l of Wash Solution II, centrifuging for 5-10s, and repeating once;
4.3.5 discarding the liquid in the collecting pipe, centrifuging for 1min, and removing the residual liquid;
4.3.6 adding a proper amount of RNase-free water preheated at 95 ℃, centrifuging at the maximum rotating speed for 20-30s, and collecting a gRNA solution;
5. preparation of Cas9mRNA
5.1 preparation of in vitro transcription template for Cas9 mRNA: the pSP6-2sNLS-spCas9 vector (37 ℃, 4h or more) was linearized by Xba I single digestion; taking a small amount of electrophoresis to confirm that linearization is complete, and directly recovering a linearization product;
5.2 in vitro transcription of Cas9mRNA, the mRNA in vitro transcription system is shown in Table 5;
TABLE 5 Cas9mRNA in vitro transcription System
Figure BDA0002896381140000051
5.3 addition of polyA sequence, mRNA recovered (FIG. 4) can be used for microinjection;
TABLE 6 mRNA plus polyA reaction System
Figure BDA0002896381140000052
6. Preparation F0Zebra fish substitute
6.1 mixing Cas9mRNA and gRNA, injecting into a zebra fish embryo of a single cell, and simultaneously taking the same batch of uninjected embryos as a control, wherein Cas9mRNA 300-500pg and gRNA 25-200 pg;
6.2 taking the embryo with normal phenotype after 2-4dpf injection, extracting genome DNA, and detecting the mutation efficiency of the target site by PCR and T7E1 enzyme digestion (figure 5);
6.3 recovering the uncut band, TA cloning and sequencing, and detecting the mutation type;
6.4 selection of F for injection in the same batch with higher mutation efficiency and higher survival rate0Feeding the embryo to sexual maturity;
6.5 carrying out outcrossing with wild adult fish, mixing 3-5F 1 embryos with 1dpf into a group to extract genome DNA;
6.6 detecting the mutation condition of the target site by PCR and enzyme digestion;
6.7 recovering the band which is not cut, TA clone sequencing and determining the mutation type;
6.8 selection of F producing potent mutations0Mating fish and breeding in large quantities F1
7. Screening for F carrying the mutation at the target site1Adult fish
7.1 mixing F1Raising to be large enough until tail fins are suitable to be cut;
7.2F1cutting tail fin and extracting gene group of adult fish, carrying out gene detection one by PCR and enzyme digestion, and screening out F1Heterozygote;
7.3 recovering the band which is not cut open and TA clone, sequencing and determining the mutation type;
8. selecting female fish and male fish with the same mutation from the F1 generation mutation body weight, hybridizing to obtain F2 generation, culturing at 28.5 ℃, taking partial embryos at 4dpf, independently extracting genome DNA of each embryo, and taking primer pairs with the following primer sequences:
9. the efficiency of identifying homozygous mutations by PCR banding analysis was further identified by sequencing (figure 5).

Claims (2)

  1. The preparation method of the zebra fish with the LDLR gene deletion is characterized by comprising the following steps:
    1) determining an LDLR target site according to the LDLR gene sequence;
    2) designing an Oligo sequence according to the LDLR target site;
    3) constructing a gRNA in vitro transcription vector;
    4) PCR is carried out to obtain a gRNA in vitro transcription template;
    5) carrying out in-vitro transcription on the template obtained in the step 4 to obtain gRNA;
    6) preparing an in vitro transcription template of Cas9 mRNA;
    7) in vitro transcription of Cas9mRNA
    8) Adding a polyA sequence, and recovering Cas9 mRNA;
    9) cas9mRNA and gRNA are mixed and injected into zebra fish embryos at the single cell stage;
    10) f is to be0Feeding the embryo to sexual maturity;
    11) outcrossing with wild adult fish, screening F0
    12) Selection of F producing efficient mutations0Selfing and screening F1
    13) From F1Selecting female fish and male fish with the same mutation from the generation mutants, and hybridizing to obtain F2Generation;
    14) screening LDLR gene knockout homozygote to obtain the stably inherited LDLR gene deletion zebra fish.
  2. 2. The use of the LDLR gene deleted zebrafish of claim 1, wherein the LDLR gene deleted zebrafish is used for the study of vascular embolism.
CN202110043825.1A 2021-01-13 2021-01-13 Preparation method of zebra fish with LDLR gene deletion Withdrawn CN112813106A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110043825.1A CN112813106A (en) 2021-01-13 2021-01-13 Preparation method of zebra fish with LDLR gene deletion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110043825.1A CN112813106A (en) 2021-01-13 2021-01-13 Preparation method of zebra fish with LDLR gene deletion

Publications (1)

Publication Number Publication Date
CN112813106A true CN112813106A (en) 2021-05-18

Family

ID=75869249

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110043825.1A Withdrawn CN112813106A (en) 2021-01-13 2021-01-13 Preparation method of zebra fish with LDLR gene deletion

Country Status (1)

Country Link
CN (1) CN112813106A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105647969A (en) * 2016-02-16 2016-06-08 湖南师范大学 Method for breeding stat1a (signal transducer and activator of transcription 1) gene-deleted zebra fish through gene knockout
US20190037817A1 (en) * 2016-02-01 2019-02-07 Hebei Invivo Biotech Inc Ldl receptor gene knockout, genetically-engineered hamster

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190037817A1 (en) * 2016-02-01 2019-02-07 Hebei Invivo Biotech Inc Ldl receptor gene knockout, genetically-engineered hamster
CN105647969A (en) * 2016-02-16 2016-06-08 湖南师范大学 Method for breeding stat1a (signal transducer and activator of transcription 1) gene-deleted zebra fish through gene knockout

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIU C 等: "Modeling hypercholesterolemia and vascular lipid accumulation in LDL receptor mutant zebrafish", 《J LIPID RES》 *
无: "Accession. XM_005163870.4,PREDICTED: Danio rerio low density lipoprotein receptor a (ldlra), transcript variant X1, mRNA", 《GENBANK》 *

Similar Documents

Publication Publication Date Title
CN107475300B (en) Construction method and application of Ifit3-eKO1 gene knockout mouse animal model
CN106047930B (en) Preparation method of Flox rat with conditional knockout of PS1 gene
CN106318934B (en) Gene complete sequence of carrot β (1,2) xylose transferase and plasmid construction of CRISPR/CAS9 for transfecting dicotyledonous plants
AU2017101108A4 (en) Construction method of animal model of mucopolysaccharidosis type II and use thereof
EP3381278B1 (en) Method for preparing a canine model of atherosclerosis
CN106244557A (en) Rite-directed mutagenesis ApoE gene and the method for LDLR gene
CN110684777B (en) Application of isolated nucleotide sequence in construction of zebra fish with reduced intramuscular stings
CN113736787A (en) gRNA of targeted mouse Atp7b gene and method for constructing Wilson disease mouse model
CN110643636A (en) Megalobrama amblycephala MSTNa & b gene knockout method and application
CN105274141A (en) Transgenic vector for target mutation of primordial germ cells, method for preparing transgenic vector and application thereof
CN108866102B (en) Construction method of Adgrv1 gene Y6236fsX1 mutant animal model
CN112410341B (en) Mouse model construction method capable of inducing specific elimination of neutrophils
CN110066805A (en) The method of gene knockout breeding adgrf3b Gene Deletion zebra fish
CN106282230A (en) The method of rite-directed mutagenesis LDLR gene
CN108018315A (en) A kind of application of separated gene order in the blue or green Medaka albefaction strain of Japan is prepared
CN108251456B (en) Preparation method of atherosclerosis mouse model with NOD genetic background
CN113249409A (en) BMI1 gene-deleted zebra fish
CN112695034A (en) Preparation method of zebra fish with ApoE gene deletion
CN112680479A (en) Preparation method of zebra fish with CYP1B1 gene deletion
CN112813106A (en) Preparation method of zebra fish with LDLR gene deletion
CN106244556A (en) The method of rite-directed mutagenesis ApoE gene
CN113558011A (en) Method for establishing sjogren syndrome animal model based on gamma-secretase activated protein gene
CN111972355A (en) Mouse model of GSDIa type glycogen storage disease and construction method thereof
CN113215199A (en) Klotho+/-Gene deletion zebra fish
CN110331172B (en) Method for constructing whitened hamster model based on CRISPR-Cas9 system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20210518

WW01 Invention patent application withdrawn after publication